Stocks · Health care · Pharmaceutical Preparations

Seres Therapeutics, Inc.

MCRB Clue Score46
United States Fiscal year ends December CIK 0001609809 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

By person

6 insiders · 16 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Matthew R Henn
See Remarks
—
$23.45K (4) scheduled
−$23.45K
7,995
$36.38K
—
Teresa L. Young
See Remarks
—
$18.66K (2) scheduled
−$18.66K
8,557
$38.93K
—
Eric D. Shaff
Director
—
$9.09K (4) scheduled
−$9.09K
12,499
$56.87K
—
Thomas DesRosier
See Remarks
—
$2.94K (4) scheduled
−$2.94K
8,117
$36.93K
—
Kelly Brady
See Remarks
—
$735.47 (2)
−$735.47
8,679
$39.49K
+2.8%
Moltke Lisa von
See Remarks
—
—
—
39,875
$181.43K
+31.1%

No percentages here. This company's share count has moved by a factor of 19.9 over the window, from 8,754,570 to 174,358,753 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.